tykhr
sign in
free sign up
Alnylam Pharmaceuticals Inc
Biotechnology
Healthcare
ALNY
131 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
452.83
52 week high
482.13
high
457.47
52 week low
0.00
low
450.50
growth
65.92 %
previous Close
458.92
P/E ratio
market cap
51.14 B
div yield
0
usd
Jun 2025
qoq
revenue
774 M
30.21 %
net incoming
-66.28 M
-15.31 %
eps
0.00 %
3.00 %
eps surprise
148.77 %
net profit margin
-8.57 %
1.00 %
operating incoming
-16.20 M
-189.61 %
net change in cash
93.61 M
74.66 %
cash on hand
1.11 B
9.22 %
cost of revenue
0.00 %
top